NCT03340662View on ClinicalTrials.gov

Study Evaluating the Effects of Food, Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of CC-122

PHASE1CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

November 9, 2017

Primary Completion Date

January 27, 2018

Study Completion Date

January 27, 2018

Conditions
Healthy Volunteer
Interventions
DRUG

CC-122

CC-122

DRUG

Itraconazole

CYP3A Inhibitor

DRUG

Fluvoxamine

CYP1A2 Inhibitor

DRUG

Rifampin

CYP3A Inducer

Trial Locations (1)

78744

PPD Phase 1 Clinic, Austin

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY

NCT03340662 - Study Evaluating the Effects of Food, Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of CC-122 | Biotech Hunter | Biotech Hunter